Ontogeny of circulating lipid metabolism in pregnancy and early childhood: a longitudinal population study

  1. Satvika Burugupalli
  2. Adam Alexander T Smith
  3. Gavriel Oshlensky
  4. Kevin Huynh
  5. Corey Giles
  6. Tingting Wang
  7. Alexandra George
  8. Sudip Paul
  9. Anh Nguyen
  10. Thy Duong
  11. Natalie Mellett
  12. Michelle Cinel
  13. Sartaj Ahmad Mir
  14. Li Chen
  15. Markus R Wenk
  16. Neerja Karnani
  17. Fiona Collier
  18. Richard Saffery
  19. Peter Vuillermin
  20. Anne-Louise Ponsonby
  21. David Burgner  Is a corresponding author
  22. Peter Meikle  Is a corresponding author
  1. Baker Heart and Diabetes Institute, Australia
  2. National University of Singapore, Singapore
  3. Singapore Institute for Clinical Sciences, A*STAR, Singapore
  4. Deakin University, Australia
  5. Murdoch Children's Research Institute, Australia
  6. The Florey Institute of Neuroscience and Mental Health, Australia
  7. Murdoch Children's Research Institute, Australia

Abstract

Background: There is mounting evidence that in utero and early life exposures may predispose an individual to metabolic disorders in later life; and dysregulation of lipid metabolism is critical in such outcomes. However, there is limited knowledge about lipid metabolism and factors causing lipid dysregulation in early life that could result in adverse health outcomes in later life. We studied the effect of antenatal factors such as gestational age, birth weight and mode of birth on lipid metabolism at birth; changes in the circulating lipidome in the first four years of life and the effect of breastfeeding in the first year of life. From this study, we aim to generate a framework for deeper understanding into factors effecting lipid metabolism in early life, to provide early interventions for those at risk of developing metabolic disorders including cardiovascular diseases.

Methods and findings: We performed comprehensive lipid profiling of 1074 mother-child dyads in the Barwon Infant Study (BIS), a population based pre-birth cohort and measured 776 distinct lipid species across 42 lipid classes using ultra high-performance liquid chromatography (UHPLC). We measured lipids in 1032 maternal serum samples at 28 weeks' gestation, 893 cord serum samples at birth, 793, 735, and 511 plasma samples at six, twelve months, and four years, respectively. The lipidome differed between mother and newborn and changed markedly with increasing child's age. Cord serum was enriched with long chain poly-unsaturated fatty acids (LC-PUFAs), and corresponding cholesteryl esters relative to the maternal serum. Alkenylphosphatidylethanolamine species containing LC-PUFAs increased with child's age, whereas the corresponding lysophospholipids and triglycerides decreased. We performed regression analyses to investigate the associations of cord serum lipid species with antenatal factors: gestational age, birth weight, mode of birth and duration of labor. Majority of the cord serum lipids were strongly associated with gestational age and birth weight, with most lipids showing opposing associations. Each mode of birth showed an independent association with cord serum lipids. Breastfeeding had a significant impact on the plasma lipidome in the first year of life, with upto 17-fold increases in a few species of alkyldiaclylglycerols at 6 months of age.

Conclusions: This study sheds light on lipid metabolism in infancy and early childhood and provide a framework to define the relationship between lipid metabolism and health outcomes in early childhood.

Funding Statement: This work was supported by the A*STAR-NHMRC joint call funding (1711624031).

Data availability

Due to the consent obtained during recruitment process, it is not possible to make all data publicly available. Access to BIS data including all data used in this paper may be requested through the BIS Steering Committee by contacting the corresponding author. Requests to access cohort data are considered on scientific and ethical grounds and, if approved, provided under collaborative research agreements. Deidentified cohort data can be provided in Stata or CSV format. All statistical methods used are referenced within the methods section. Data that is not subject to data-sharing restrictions can be found in Supplementary File 1. Additional project information, including cohort data description and access procedures, is available at the project's website https://www.barwoninfantstudy.org.au

Article and author information

Author details

  1. Satvika Burugupalli

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Adam Alexander T Smith

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Gavriel Oshlensky

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Kevin Huynh

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Corey Giles

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourn, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Tingting Wang

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Alexandra George

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Sudip Paul

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Anh Nguyen

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Thy Duong

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  11. Natalie Mellett

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  12. Michelle Cinel

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  13. Sartaj Ahmad Mir

    Department of Biochemistry, National University of Singapore, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  14. Li Chen

    Singapore Institute for Clinical Sciences, A*STAR, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  15. Markus R Wenk

    Department of Biochemistry, National University of Singapore, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  16. Neerja Karnani

    Singapore Institute for Clinical Sciences, A*STAR, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  17. Fiona Collier

    School of Medicine, Deakin University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5438-480X
  18. Richard Saffery

    Murdoch Children's Research Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  19. Peter Vuillermin

    School of Medicine, Deakin University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  20. Anne-Louise Ponsonby

    The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6581-3657
  21. David Burgner

    Infection and Immunity, Murdoch Children's Research Institute, Parkville, Australia
    For correspondence
    david.burgner@mcri.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8304-4302
  22. Peter Meikle

    Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
    For correspondence
    peter.meikle@baker.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2593-4665

Funding

National Health and Medical Research Council (A*STAR-NHMRC joint call funding (1711624031).)

  • Peter Meikle

National Health and Medical Research Council (A*STAR-NHMRC joint call funding (1711624031).)

  • Markus R Wenk
  • Neerja Karnani
  • Fiona Collier
  • Richard Saffery
  • Peter Vuillermin
  • Anne-Louise Ponsonby
  • David Burgner

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The original study was granted by the Barwon Health Human Research and Ethics Committee (HREC 10/24).

Copyright

© 2022, Burugupalli et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,608
    views
  • 254
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Satvika Burugupalli
  2. Adam Alexander T Smith
  3. Gavriel Oshlensky
  4. Kevin Huynh
  5. Corey Giles
  6. Tingting Wang
  7. Alexandra George
  8. Sudip Paul
  9. Anh Nguyen
  10. Thy Duong
  11. Natalie Mellett
  12. Michelle Cinel
  13. Sartaj Ahmad Mir
  14. Li Chen
  15. Markus R Wenk
  16. Neerja Karnani
  17. Fiona Collier
  18. Richard Saffery
  19. Peter Vuillermin
  20. Anne-Louise Ponsonby
  21. David Burgner
  22. Peter Meikle
(2022)
Ontogeny of circulating lipid metabolism in pregnancy and early childhood: a longitudinal population study
eLife 11:e72779.
https://doi.org/10.7554/eLife.72779

Share this article

https://doi.org/10.7554/eLife.72779

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Bo Zheng, Bronner P Gonçalves ... Caoyi Xue
    Research Article

    Background:

    In many settings, a large fraction of the population has both been vaccinated against and infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, quantifying the protection provided by post-infection vaccination has become critical for policy. We aimed to estimate the protective effect against SARS-CoV-2 reinfection of an additional vaccine dose after an initial Omicron variant infection.

    Methods:

    We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared reinfection incidence by post-infection vaccination status in individuals initially infected during the April–May 2022 Omicron variant surge in Shanghai and who had been vaccinated before that period. Cox models were fit to estimate adjusted hazard ratios (aHRs).

    Results:

    275,896 individuals were diagnosed with real-time polymerase chain reaction-confirmed SARS-CoV-2 infection in April–May 2022; 199,312/275,896 were included in analyses on the effect of a post-infection vaccine dose. Post-infection vaccination provided protection against reinfection (aHR 0.82; 95% confidence interval 0.79–0.85). For patients who had received one, two, or three vaccine doses before their first infection, hazard ratios for the post-infection vaccination effect were 0.84 (0.76–0.93), 0.87 (0.83–0.90), and 0.96 (0.74–1.23), respectively. Post-infection vaccination within 30 and 90 days before the second Omicron wave provided different degrees of protection (in aHR): 0.51 (0.44–0.58) and 0.67 (0.61–0.74), respectively. Moreover, for all vaccine types, but to different extents, a post-infection dose given to individuals who were fully vaccinated before first infection was protective.

    Conclusions:

    In previously vaccinated and infected individuals, an additional vaccine dose provided protection against Omicron variant reinfection. These observations will inform future policy decisions on COVID-19 vaccination in China and other countries.

    Funding:

    This study was funded the Key Discipline Program of Pudong New Area Health System (PWZxk2022-25), the Development and Application of Intelligent Epidemic Surveillance and AI Analysis System (21002411400), the Shanghai Public Health System Construction (GWVI-11.2-XD08), the Shanghai Health Commission Key Disciplines (GWVI-11.1-02), the Shanghai Health Commission Clinical Research Program (20214Y0020), the Shanghai Natural Science Foundation (22ZR1414600), and the Shanghai Young Health Talents Program (2022YQ076).

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article Updated

    Background:

    The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).

    Methods:

    Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.

    Results:

    Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).

    Conclusions:

    Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding:

    Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.